LIXIM Trademark

Trademark Overview

On Tuesday, May 8, 2012, a trademark application was filed for LIXIM with the United States Patent and Trademark Office. The USPTO has given the LIXIM trademark a serial number of 79114941. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Monday, May 9, 2022. This trademark is owned by Drossapharm AG. The LIXIM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations in the field of human medicine in the nature of pharmaceutical preparations for the treatment mouth diseases, pharmaceutical preparations for the treatment of rheumatic diseases, pharmaceutical preparations for the treatment of the musculoskeletal system, and pharmaceutical preparations for the treatment for the cardiovascular system
lixim

General Information

Serial Number79114941
Word MarkLIXIM
Filing DateTuesday, May 8, 2012
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateMonday, May 9, 2022
Registration Number4303358
Registration DateTuesday, March 19, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 27, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations in the field of human medicine in the nature of pharmaceutical preparations for the treatment mouth diseases, pharmaceutical preparations for the treatment of rheumatic diseases, pharmaceutical preparations for the treatment of the musculoskeletal system, and pharmaceutical preparations for the treatment for the cardiovascular system

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, October 25, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDrossapharm AG
Party Type30 - Original Registrant
Legal Entity Type11 - Company
AddressBASEL CH4002
CH
Party NameDrossapharm AG
Party Type20 - Owner at Publication
Legal Entity Type11 - Company
AddressBASEL CH4002
CH
Party NameDrossapharm AG
Party Type10 - Original Applicant
Legal Entity Type11 - Company
AddressBASEL CH4002
CH

Trademark Events

Event DateEvent Description
Saturday, November 26, 2022NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Saturday, November 26, 2022DEATH OF INTERNATIONAL REGISTRATION
Friday, August 7, 2020TOTAL INVALIDATION PROCESSED BY THE IB
Tuesday, July 14, 2020TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Tuesday, July 14, 2020INVALIDATION PROCESSED
Thursday, June 25, 2020TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, October 25, 2019CANCELLED SECTION 71
Monday, March 19, 2018COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Saturday, December 14, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, November 25, 2013FINAL DISPOSITION NOTICE SENT TO IB
Monday, November 25, 2013FINAL DISPOSITION PROCESSED
Wednesday, June 19, 2013FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, March 19, 2013REGISTERED-PRINCIPAL REGISTER
Monday, February 11, 2013EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Friday, February 8, 2013CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Thursday, January 24, 2013ASSIGNED TO PETITION STAFF
Tuesday, January 1, 2013NOTIFICATION PROCESSED BY IB
Wednesday, December 26, 2012TEAS POST PUBLICATION AMENDMENT RECEIVED
Friday, December 21, 2012EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, November 27, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 27, 2012PUBLISHED FOR OPPOSITION
Wednesday, November 7, 2012NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, November 7, 2012NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, November 7, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, October 19, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, October 18, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 27, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 27, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, September 22, 2012ASSIGNED TO LIE
Saturday, September 15, 2012REFUSAL PROCESSED BY IB
Friday, September 14, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 30, 2012NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, August 30, 2012REFUSAL PROCESSED BY MPU
Thursday, August 30, 2012NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, August 29, 2012NON-FINAL ACTION WRITTEN
Tuesday, August 28, 2012ASSIGNED TO EXAMINER
Saturday, August 4, 2012APPLICATION FILING RECEIPT MAILED
Tuesday, July 31, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, July 26, 2012SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

lixim preparations pharmaceutical treatment diseases system rheumatic musculoskeletal cardiovascular mouth medicine